![]() |
|
#1
|
|||
|
|||
|
LONDON (Reuters) - Demand for new medicines helped GlaxoSmithKline grow earnings in the second quarter and the drugmaker is set for big gains in the rest of 2016 thanks to a weak pound, after Britain's vote to leave the European Union. ??????? ??????: GSK outlook brightens as Brexit brings currency windfall || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|